European Medicines Agency Accepts Tofersen Marketing Authorization Application to Treat Rare, Genetic Form of ALS PressReach · Dec 6, 2022
Global pharma giants partner Singapore researchers to boost innovation in biologics and vaccines manufacturing PressReach · Dec 6, 2022
Compugen's COM701 (anti-PVRIG) in Dual and Triple Combination Demonstrates Preliminary Durable Anti-Tumor Activity and Immune Activation in Patients with Platinum Resistant Ovarian Cancer PressReach · Dec 6, 2022
Emergent BioSolutions Announces U.S. FDA Acceptance and Priority Review of Supplemental New Drug Application for Over-the-Counter NARCAN® (naloxone HCl) Nasal Spray PressReach · Dec 6, 2022
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PressReach · Dec 6, 2022
iBio® to Showcase the RubrYc® Discovery Engine During Poster Presentations at Antibody Engineering & Therapeutics Conference 2022 PressReach · Dec 6, 2022
AbbVie Launches Strategic Collaboration with HotSpot Therapeutics to Further Expand Immunology Pipeline PressReach · Dec 6, 2022
HTG Technology Featured Across Numerous Abstracts at Upcoming Scientific Conferences PressReach · Dec 6, 2022
Aurora Cannabis Repurchases ~$103 Million Principal Amount of Convertible Notes; Balance Sheet Among Strongest in Industry PressReach · Dec 5, 2022